BioCryst Pharmaceuticals | Beban Penjualan Dan Administrasi

Selling And Administration Expenses Perubahan Tanggal
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Daiichi Sankyo JPY 141.03B 4.45B 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Incyte USD 293.86M 25.97M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
PTC Therapeutics USD 76.29M 4.6M 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



BioCryst Pharmaceuticals Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Apr 2024.